GLP-1
(Journal Article): Pancreatic and intestinal processing of proglucagon in man.
0rskov C, Holst JJ, Poulsen S, Kirkegaard P
IN:
Diabetologia
1987; 30:874-881
Impact Factor(s) of Diabetologia: 5.583 (2004), 5.689 (2003), 5.136 (2002), 6.299 (2001)
ABSTRACT:
We developed antisera and radioimmunoassays against synthetic replicas of glucagon-like peptide-1 (1-36) and -2, predicted products of the glucagon precursor, and against glucagon-...
Click HERE for details
(Journal Article): Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.
Hvidberg A, Nielsen MT, Hilsted J, 0rskov C, Holst JJ
IN:
Metabolism
1994; 43(1):104-108
Impact Factor(s) of Metabolism: 2.143 (2004), 2.013 (2003), 1.931 (2001)
ABSTRACT:
The newly discovered intestinal hormone, glucagon-like peptide-1 (GLP-1) (proglucagon 78-107amide), stimulates insulin secretion and inhibits glucagon secretion in man and may ther...
Click HERE for details
(Journal Article): Glucagon-like peptide I analogues: effects on insulin secretion and adenosine 3',5'-monophosphate formation.
Gefel D, Hendrick GK, Mojsov S, Habener J, Weir GE
IN:
Endocrinology
1990; 126:2164-2168
Impact Factor(s) of Endocrinology: 5.151 (2004), 5.063 (2003), 5.095 (2002), 4.971 (2001)
ABSTRACT:
Glucagon-like peptide 1-(7-37) [GLP-I-(7-37)] is a 31-amino acid hormone which may have an important role in the regulation of insulin secretion, It is processed from preproglucago...
Click HERE for details
(Journal Article): Glucagon-like peptide 1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
Gallwitz B, Schmidt WE, Conlon JM, Creutzfeldt W
IN:
J Mol Endocrinol
1990; 5:33-39
Impact Factor(s) of J Mol Endocrinol: 3.855 (2004), 3.701 (2003), 4.359 (2002), 3.649 (2001)
ABSTRACT:
Glucagon-like peptide-1(7-36)amide (GLP-1(7-36)amide) is a potent stimulator of insulin secretion. Receptors for this hormone have been found on different insulinoma-derived cell l...
Click HERE for details
(Journal Article): Structure-activity studies of glucagon-like peptide-l.
Adelhorst K, Hedegaard BB, Knudsen LB, Kirk O
IN:
J Biol Chem
1994; 269:6275-6278
Impact Factor(s) of J Biol Chem: 6.355 (2004), 6.482 (2003), 7.258 (2001)
ABSTRACT:
A series of analogs of glucagon-like peptide-1 (GLP-1) was made replacing each amino acid with L-alanine to identify side-chain functional groups required for interaction with the ...
Click HERE for details
(Journal Article): Is GLP-l (9-36)amide an endogenous antagonist at GLP-l receptors?
Grandt D, Sieburg B, Sievert J,
IN:
Digestion
1994; 55:302.-
Impact Factor(s) of Digestion: 1.473 (2004), 1.672 (2002), 1.89 (2001)
ABSTRACT:
n.a.
Click HERE for details
(Journal Article): GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
Schjoldager BT, Mortensen PE, Christiansen J, 0rskov C, Holst JJ
IN:
Dig Dis Sei
1989; 34(5):703-708
ABSTRACT:
Glucagon-like peptide 1 amide (GLP-1 amide), a predicted product of the glucagon gene (proglucagon 72-107-amide), and truncated GLP-1 (proglucagon 78-107-amide), recently isolated ...
Click HERE for details
(Journal Article): Biologieal effects and metabolic rates of glucagon-like peptide-1 7-36 amide and glucagon-like peptide-1 7-37 in healthy subjects are indistinguishable.
0rskov C, Wettergren A, Holst JJ
IN:
Diabetes
1993; 42:658-661
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)
ABSTRACT:
The biological effects and the metabolism of the intestinal hormone glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 were studied in normal healthy subjects. GLP-1...
Click HERE for details
|
Contribute
to this subject area!
|
|
|